Hematology Today—July 6, 2026
This week’s Hematology update highlights regulatory progress, positive…
Cell and Gene Therapy Today—July 2, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress,…
Immunology Today—July 1, 2026
This week’s Immunology update highlights regulatory decisions, clinical trial…
AbbVie's Apogee Acquisition Valued at $10.9B. | Lucid Diligence Brief
AbbVie’s Apogee deal adds zumilokibart and asthma assets as immunology growth…
Immunology Today—June 24, 2026
This week’s Immunology update highlights regulatory approvals, advancing late-…
Neuroscience Today—June 17, 2026
This week’s Neuroscience update highlights regulatory decisions, late-stage…
Hematology Today—June 15, 2026
This week’s Hematology update highlights regulatory actions, clinical progress,…
Neuroscience Today—June 10, 2026
This week’s Neuroscience update highlights regulatory approvals, positive Phase…
Hematology Today—June 2, 2026
This week’s Hematology update highlights ASCO 2026 readouts, regulatory…
Immunology Today—May 13, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Neuroscience Today—May 6, 2026
This week’s Neuroscience update highlights regulatory progress, clinical…
Neuroscience Today—April 15, 2026
This week’s Neuroscience update highlights regulatory progress, biomarker-based…